Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.
Reynes
J
J
Denisi
R
R
Massip
P
P
Izopet
J
J
Pellegrin
I
I
Segondy
M
M
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D008297:Male; D010349:Patient Compliance; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D012367:RNA, Viral / Q000032:analysis; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D012367:RNA, Viral; D018119:Stavudine; D016049:Didanosine